Speciality: Oncology
Description:
A warm welcome to all medical professionals joining us for this insightful session: "Understanding the Evolution in Lung Cancer - An Initiative from Manipal Hospitals." Lung cancer treatment has undergone a remarkable transformation in recent years, moving from broad-spectrum therapies to highly precise, personalized approaches. Manipal Hospitals, at the forefront of medical innovation, is dedicated to integrating these advancements to offer cutting-edge care, improving patient outcomes and quality of life. This session, featuring renowned expert Dr. Lalit Sharma, will delve into the pivotal shifts in diagnostics, targeted therapies, immunotherapies, and surgical techniques that are redefining lung cancer management.
The journey of lung cancer treatment has seen significant breakthroughs, driven by a deeper understanding of the disease's molecular landscape. From early detection methods to the development of novel drugs that target specific genetic mutations, the evolution has been profound. Dr. Lalit Sharma will share his expertise on how these advancements, including precision medicine and innovative surgical procedures, are being effectively implemented at Manipal Hospitals. This initiative underscores Manipal's commitment to patient-centric care, ensuring that individuals receive tailored treatments based on their unique tumor characteristics, leading to more effective and less toxic interventions.
This webinar offers a comprehensive overview of the current best practices and future directions in lung cancer therapy. Attendees will gain valuable knowledge on the latest research, clinical trials, and multidisciplinary approaches that are crucial for optimizing patient care. Tune in to this session by Dr. Lalit Sharma and Manipal Hospitals to enhance your understanding of the dynamic field of lung cancer treatment and stay informed about the continuous progress in combating this challenging disease.
See More Webinars @ Hidoc Webinars
1.
Belgian Algorithm Reshapes Endometrial Cancer Care
2.
ASCO: Durvalumab plus FLOT beneficial for resectable gastric, GE junction cancer
3.
Nuclear missile workers are contracting cancer: They blame the bases
4.
On all CAR-T products, the FDA is calling for a new boxed warning.
5.
ASCO Future Focus: Metastatic Breast Cancer: Future Focus from the American Society of Clinical Oncology
1.
Understanding SVR Normal Range: A Guide to Achieving Optimal Health
2.
Consensus Recommendations for Healthy Hematologic Aging
3.
The Role of Alanine Aminotransferase in Liver Health and Disease
4.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
5.
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Efficient Management of First line ALK-rearranged NSCLC - Part II
2.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
3.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
4.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
5.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation